|
1) Pischon T, Girman CJ, Sacks FM, et al. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation. 2005; 112: 3375-83
|
|
|
|
2) Okamura T, Kokubo Y, Watanabe M, et al. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study. Atherosclerosis. 2009; 203: 587-92
|
|
|
|
|
|
3) Tanabe N, Iso H, Okada K, et al. Serum total and non-high-density lipoprotein cholesterol and the risk prediction of cardiovascular events – the JALS-ECC –. Circ J. 2010; 74: 1346-56
|
|
|
|
|
4) Noda H, Iso H, Irie F, et al. Association between non-high-density lipoprotein cholesterol concentrations and mortality from coronary heart disease among Japanese men and women: the Ibaraki Prefectural Health Study. J Atheroscler Thromb. 2010; 17: 30-6
|
|
|
|
|
|
5) Kitamura A, Noda H, Nakamura M, et al. Association between non-high-density lipoprotein cholesterol levels and the incidence of coronary heart disease among japanese: the Circulatory Risk in Communities Study (CIRCS). J Atheroscler Thromb. 2011; 18: 454-63
|
|
|
|
|
|
6) Okamura T, Kokubo Y, Watanabe M, et al. Triglycerides and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort: the Suita study. Atherosclerosis. 2010; 209: 290-4
|
|
|
|
|
|
7) Sugimoto K, Isobe K, Kawakami Y, et al. The relationship between non-HDL Cholesterol and other lipid parameters in Japanese subjects. J Atheroscler Thromb. 2005; 12: 7-10
|
|
|
|
|
|
8) Shimano H, Arai H, Harada-Shiba M, et al. Proposed guidelines for hypertriglyceridemia in Japan with non-HDL Cholesterol as the second target. J Atheroscler Thromb. 2008; 15: 116-21
|
|
|
|
|
|
9) Miller WG, Myers GL, Sakurabayashi I, et al. Seven direct methods for measuring HDL and LDL cholesterol compared with ultra-centrifugation reference measurement proce-dures. Clin Chem. 2010; 56: 977-86
|
|
|
|
|
|
10) van Deventer HE, Miller WG, Myers GL, et al. Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population. Clin Chem. 2011; 57: 490-501
|
|
|
|
|
|
11) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486-97
|
|
|
|
|
|
12) Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Eur J Cardiovasc Prev Rehabil. 2007; 14 Suppl 2: S1-113
|
|
|
|
|
|
13) Matsuzaki M, Kita T, Mabuchi H, et al. Japan Lipid Intervention Trial. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J. 2002; 66: 1087-95
|
|
|
|
|
|
14) NIPPON DATA80 Research Group. Risk as-sessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J. 2006; 70: 1249-55
|
|
|
|
|
|
15) Arima H, Yonemoto K, Doi Y, et al. Development and validation of a cardiovascular risk prediction model for Japanese: the Hisayama study. Hypertens Res. 2009; 32, 1119–22
|
|
|
|
|
|
16) Matsumoto M, Ishikawa S, Kayaba K, et al. Risk charts illustrating the 10-year risk of myocardial infarction among residents of Japanese rural communities: the JMS Cohort Study. J Epidemiol. 2009; 19: 94-100
|
|
|
|
|
|
17) Ishikawa S, Matsumoto M, Kayaba K, et al. Risk charts illustrating the 10-year risk of stroke among residents of Japanese rural communities: the JMS Cohort Study. J Epidemiol. 2009; 19: 101-6
|
|
|
|
|
|
18) Imamura T, Doi Y, Arima H, et al. LDL chole-sterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke. 2009; 40: 382-8
|
|
|
|
|
|
19) Amarenco P, Bogousslavsky J, Callahan A 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006; 355: 549-59
|
|
|
|
|
|
20) Soyama Y, Miura K, Morikawa Y, et al. High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: the Oyabe Study. Stroke. 2003; 34: 863-8
|
|
|
|
|
|
21) Okamura T, Hayakawa T, Kadowaki T, et al. The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9. 6-year follow-up study in the Japanese general population. Atherosclerosis. 2006; 184: 143-50
|
|
|
|
|
|
22) Sawamura T, Kume N, Aoyama T, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997; 386: 73-7
|
|
|
|
|
|
23) Inoue N, Okamura T, Kokubo Y, et al. LOX index, a novel predictive biochemical marker for coronary heart disease and stroke. Clin Chem. 2010; 56: 550-8
|
|
|
|
|